Aminocaproic Acid Impurity
|
氨基己酸杂质
|
19837-09-3
|
Sodium picosulfate M1Z1
|
匹可硫酸钠M1Z1
|
16985-05-0
|
3R, 5R epimer (impurity b)
|
3R,5R差向异构体(杂质B)
|
|
Salkeliptin impurity k
|
沙克列汀杂质K
|
|
Salkeliptin impurity q
|
沙克列汀杂质Q
|
|
Omadacycline Impurity 3YWP-IM-03
|
奥玛环素杂质YWP-IM-03
|
2272886-35-6
|
Amlodipine Impurity D
|
氨氯地平杂质D
|
113994-41-5
|
Levofloxacin Impurity D
|
左氧氟沙星杂质D
|
178964-53-9
|
Ceftriaxone EP impurity A
|
头孢曲松钠EP杂质A
|
97164-54-0
|
Bupropion Related Compound A HCl
|
安非他酮杂质 A HCl
|
1049718-72-0
|
Nicergoline Impurity A
|
尼麦角林EP杂质A
|
38536-28-6
|
Linezolid ImpurityLNZA-E
|
利奈唑胺杂质LNZA-E
|
1391068-25-9
|
Lombartinib impurity 22
|
仑伐替尼杂质22
|
417724-81-3
|
Calcium Levofolinate Impurity
|
叶酸钙杂质
|
39707-61-4
|
Lysine Acetylsalicylate Impurity H
|
赖氨匹林EP杂质H
|
121893-23-0
|
formaldehyde O-methyl oxime
|
O-甲基甲醛肟
|
62479-73-6
|
Trimetazidine Impurity
|
曲美他嗪亚硝胺杂质
|
92432-50-3
|
Salkeliptin impurity b
|
沙克列汀杂质B
|
|
Salkeliptin impurity h
|
沙克列汀杂质H
|
|
Omadacycline Impurity 2YWP-IM-02
|
奥玛环素杂质YWP-IM-02
|
885112-31-2
|
Tryptophan EP Impurity F
|
色氨酸EP杂质F
|
145545-23-9
|
Diltiazem EP Impurity B
|
地尔硫卓EP杂质B
|
87447-47-0
|
5,6-trans Travoprost
|
5,6-反式-曲伏前列素
|
1563176-59-9
|
Afzosin hydrochloride impurity e
|
盐酸阿夫唑嗪杂质E
|
|
Apatamide impurity 2
|
阿帕他胺杂质2
|
133239-92-0
|
Argatroban Impurity I
|
阿加曲班杂质I
|
189264-02-6
|
2-Hydroxypropylcarbamate
|
碳13尿 2-羟丙基氨基甲酸酯
|
17464-96-9
|
Ilaprazole Impurity
|
艾普拉唑杂质
|
1378653-43-0
|
3S, 5S epimer (impurity b)
|
3S,5S差向异构体(杂质B)
|
|
Afzosin hydrochloride impurity a
|
盐酸阿夫唑嗪杂质A
|
|
Salkeliptin impurity o
|
沙克列汀杂质O
|
|
Sugammadex Org226100-1
|
舒更葡糖钠杂质18 Org226100-1
|
2768160-22-9
|
Vitamin K1 Impurity G
|
维生素K1杂质G
|
34044-00-3
|
1-Propanol, 2-(2-hydroxypropoxy)-, 1-carbamate
|
碳13尿 3-(2-羟基丙氧基)丙基氨基甲酸酯
|
2271317-97-4
|
1-hydroxypropyl-2-yl-Carbamate
|
碳13尿 1-羟丙基-2-基-氨基甲酸酯
|
36473-03-7
|
Linagliptin Impurity 106
|
利格列汀杂质106
|
1955514-80-3
|
Decarbamoylcefoxitin Cefoxitin Impurity E
|
头孢西丁杂质E
|
2395025-32-6
|
Empagliflozin Impurity 25
|
恩格列净杂质 25
|
2452301-42-5
|
Starting material II (impurity n)
|
起始原料Ⅱ(杂质N)
|
|
Salkeliptin impurity l
|
沙克列汀杂质L
|
|
Salkeliptin impurity r
|
沙克列汀杂质R
|
|
Omadacycline Impurity 1YWP-IM-01
|
奥玛环素杂质YWP-IM-01
|
601455-29-2
|
Duloxetine Related Compound H
|
盐酸度洛西汀杂质H
|
199191-66-7
|
Bupropion Related Compound B HCl
|
安非他酮杂质 B HCl
|
1049718-43-5
|
Salbutamol Impurity L
|
盐酸左旋沙丁胺醇杂质L
|
149222-15-1
|
Dapagliflozin peroxide impurit
|
达格列净过氧化物杂质
|
2452300-94-4
|
Salkeliptin impurity c
|
沙克列汀杂质C
|
|
Salkeliptin impurity i
|
沙克列汀杂质I
|
|
2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridin-4(1H)-one
|
艾司奥美拉唑杂质5
|
301669-82-9
|
(3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydrosy-6-heptane acid,(+)phenyl ethylamine
|
匹伐他汀杂质
|
147511-70-4
|
Atorvastatin Impurity
|
阿托伐他汀内酰胺杂质
|
906552-18-9
|
BOlmesartan Medoxomil EP Impurity B
|
奥美沙坦酯脂EP杂质B
|
849206-43-5
|
Ezetimibe tetrahydropyran Impurity 56
|
依折麦布四氢呋喃杂质56
|
1296129-15-1
|
Oseltamivir Impurity
|
奥司他韦杂质
|
1415963-60-8
|
Brexpiprazole Impurity
|
二氢布瑞哌唑
|
913612-07-4
|
Lubiprostone enantioMer Impurity
|
芦比前列酮对映异构体
|
1217675-13-2
|
Upadacitinib Impurity 15
|
乌帕替尼杂质15
|
2304514-60-9
|
Indapamide Impurity A
|
吲达帕胺杂质A
|
85440-79-5
|
Demethylation impurity
|
脱甲基杂质
|
|
Salkeliptin impurity e
|
沙克列汀杂质E
|
|
Salkeliptin impurity
|
沙克列汀杂质
|
361442-04-8
|
Levofloxacin N-oxide
|
左氧氟沙星N-氧化物
|
117678-38-3
|
Betahistine Impurity 9
|
倍他司汀杂质9
|
6304-27-4
|
Esomeprazole Impurity
|
埃索美拉唑杂质
|
2362529-32-4
|
Rosuvastatin tert butyl propionate (impurity f)
|
瑞舒伐他汀丙叉叔丁酯(杂质F)
|
|
Salkeliptin impurity m
|
沙克列汀杂质M
|
|
Paliperidone Impurity
|
棕榈酸帕利哌酮光降解杂质
|
913728-83-3
|
Urea, N-(1-hydroxyethyl)-
|
碳13尿 1-(2-羟丙基)脲
|
16395-94-1
|
Sulbactam Impurity C
|
舒巴坦杂质C
|
75527-87-6
|
Afzosin hydrochloride impurity D
|
盐酸阿夫唑嗪杂质D
|
|
Ticagrelor Impurity SIP-1
|
替格瑞洛杂质SIP-1
|
2096989-56-7
|
Mometasone Furoate EP Impurity H
|
糠酸莫米松EP杂质H
|
148596-90-1
|
Ethyl Lipoicate Impurity
|
硫辛酸乙酯杂质
|
46353-61-1
|
1,1,5,5-Tetramethyl-2-(1-methylethenyl)cyclohexane
|
1,1,5,5-四甲基-2-(1-甲基乙烯基)环己烷
|
63251-38-7
|
Salkeliptin impurity d
|
沙克列汀杂质D
|
|
Salkeliptin impurity j
|
沙克列汀杂质J
|
|
Salkeliptin impurity p
|
沙克列汀杂质P
|
|
Linagliptin Impurity V
|
利格列汀杂质 V
|
2468656-63-3
|
Omadacycline Impurity 6YWP-IM-06
|
奥玛环素杂质YWP-IM-06
|
488819-64-3
|
Atorvastatin EP Impurity
|
阿托伐他汀钙杂质VI
|
148146-51-4
|
Dapagliflozin Impurity A
|
达格列净杂质A
|
1373321-04-0
|
Norepinephrine Impurity 9
|
去甲肾上腺素杂质9
|
1891319-98-4
|
Afzosin hydrochloride impurity
|
盐酸阿夫唑嗪杂质
|
81403-68-1
|
Salkeliptin impurity f
|
沙克列汀杂质F
|
|
Salkeliptin impurity a
|
沙克列汀杂质A
|
|
Salkeliptin impurity g
|
沙克列汀杂质G
|
|
ValsartanEP Impurity A
|
缬沙坦对映异构体
|
137862-87-4
|
Levonorgestrel Impurity 5
|
左炔诺孕酮杂质5
|
17092-07-8
|
Clavulanic acid Impurity C
|
克拉维酸杂质C
|
86917-74-0
|
Afzosin hydrochloride impurity B
|
盐酸阿夫唑嗪杂质B
|
|
Cefaclor EP Impurity C
|
头孢克洛EP杂质C
|
143059-69-2
|
Azacitidine α-Isomer Impurity
|
阿扎胞苷a-异构体杂质
|
157771-77-2
|
Bisoprolol Hydroxyethyl Ester Impurity D
|
比索洛尔羟乙酯杂质D
|
1346601-19-1
|
Vonoprazan Impurity Imp-47
|
伏诺拉生杂质Imp-47
|
2416241-97-7
|
Amlodipine EP Impurity D
|
氨氯地平EP杂质D
|
2138811-33-1
|
Epalrestat (E,E)-Isomer
|
依帕司他异构体(E,E)对照品
|
863988-85-6
|
DL-Pantothenic acid calcium salt
|
DL泛酸钙
|
6381-63-1
|
Enantiomer (impurity g)
|
对映异构体(杂质G)
|
|
Tert butyl rosuvastatin (impurity m)
|
瑞舒伐他汀叔丁酯(杂质M)
|
|
Salkeliptin impurity n
|
沙克列汀杂质N
|
|